254 related articles for article (PubMed ID: 9016476)
1. Treatment of respiratory failure due to respiratory syncytial virus pneumonia with natural surfactant.
Vos GD; Rijtema MN; Blanco CE
Pediatr Pulmonol; 1996 Dec; 22(6):412-5. PubMed ID: 9016476
[TBL] [Abstract][Full Text] [Related]
2. Respiratory syncytial virus infection in young Malaysian children.
Chan P; Goh A
Singapore Med J; 1999 May; 40(5):336-40. PubMed ID: 10489491
[TBL] [Abstract][Full Text] [Related]
3. Surfactant replacement therapy in RSV-induced acute respiratory distress syndrome (ARDS).
Goh AY; Chan PW; Roziah M
Singapore Med J; 1999 Feb; 40(2):113-6. PubMed ID: 10414173
[TBL] [Abstract][Full Text] [Related]
4. [Experiences with surfactant therapy of adult respiratory distress syndrome].
Buheitel G; Scharf J; Harms D
Monatsschr Kinderheilkd; 1992 Sep; 140(9):629-32. PubMed ID: 1435815
[TBL] [Abstract][Full Text] [Related]
5. Intratracheal surfactant administration restores gas exchange in experimental adult respiratory distress syndrome associated with viral pneumonia.
van Daal GJ; So KL; Gommers D; Eijking EP; Fiévez RB; Sprenger MJ; van Dam DW; Lachmann B
Anesth Analg; 1991 May; 72(5):589-95. PubMed ID: 1850209
[TBL] [Abstract][Full Text] [Related]
6. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries.
Simoes EA; Carbonell-Estrany X
Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S13-8; discussion S18-20. PubMed ID: 12671448
[TBL] [Abstract][Full Text] [Related]
7. Surfactant treatment of full-term newborns with respiratory failure.
Auten RL; Notter RH; Kendig JW; Davis JM; Shapiro DL
Pediatrics; 1991 Jan; 87(1):101-7. PubMed ID: 1984603
[TBL] [Abstract][Full Text] [Related]
8. The need for inotropic support in a subgroup of infants with severe life-threatening respiratory syncytial viral infection.
Kim KK; Frankel LR
J Investig Med; 1997 Oct; 45(8):469-73. PubMed ID: 9394100
[TBL] [Abstract][Full Text] [Related]
9. Respiratory syncytial virus infection in adults.
Falsey AR
Semin Respir Crit Care Med; 2007 Apr; 28(2):171-81. PubMed ID: 17458771
[TBL] [Abstract][Full Text] [Related]
10. Treatment of respiratory failure with inhaled nitric oxide and high- frequency ventilation in an infant with respiratory syncytial virus pneumonia and bronchopulmonary dysplasia.
Hoehn T; Krause M; Krueger M; Hentschel R
Respiration; 1998; 65(6):477-80. PubMed ID: 9817963
[TBL] [Abstract][Full Text] [Related]
11. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.
Pediatrics; 1998 Sep; 102(3 Pt 1):531-7. PubMed ID: 9738173
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy of respiratory syncytial virus pneumonia following bone marrow transplantation.
De Vincenzo JP; Leombruno D; Soiffer RJ; Siber GR
Bone Marrow Transplant; 1996 Jun; 17(6):1051-6. PubMed ID: 8807113
[TBL] [Abstract][Full Text] [Related]
13. Predictors of respiratory failure among previously healthy children with respiratory syncytial virus infection.
Prodhan P; Sharoor-Karni S; Lin J; Noviski N
Am J Emerg Med; 2011 Feb; 29(2):168-73. PubMed ID: 20825782
[TBL] [Abstract][Full Text] [Related]
14. Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy.
Bradley JP; Bacharier LB; Bonfiglio J; Schechtman KB; Strunk R; Storch G; Castro M
Pediatrics; 2005 Jan; 115(1):e7-14. PubMed ID: 15629968
[TBL] [Abstract][Full Text] [Related]
15. [Clinical, therapeutic and developmental aspects of acute bronchiolitis in Tunisia].
Ben Jaballah N; Mnif K; Hedfi L; Hammami A; Khaldi F; Bennaceur B
Cah Anesthesiol; 1996; 44(5):423-8. PubMed ID: 9183423
[TBL] [Abstract][Full Text] [Related]
16. Clinical experience with respiratory syncytial virus vaccines.
Piedra PA
Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S94-9. PubMed ID: 12671459
[TBL] [Abstract][Full Text] [Related]
17. Sharing features of uncommon respiratory syncytial virus complications in infants.
Piastra M; Caresta E; Tempera A; Langer A; Zorzi G; Pulitanò S; Chiaretti A; Genovese O; Viola L; Tortorolo L; Polidori G
Pediatr Emerg Care; 2006 Aug; 22(8):574-8. PubMed ID: 16912626
[TBL] [Abstract][Full Text] [Related]
18. The impact of infection with human metapneumovirus and other respiratory viruses in young infants and children at high risk for severe pulmonary disease.
Klein MI; Coviello S; Bauer G; Benitez A; Serra ME; Schiatti MP; Delgado MF; Melendi GA; Novalli L; Pena HG; Karron RA; Kleeberger SR; Polack FP
J Infect Dis; 2006 Jun; 193(11):1544-51. PubMed ID: 16652283
[TBL] [Abstract][Full Text] [Related]
19. Respiratory syncytial virus.
Shapiro JM; Jean RE
N Engl J Med; 2001 Oct; 345(15):1132-3. PubMed ID: 11596600
[No Abstract] [Full Text] [Related]
20. Lack of usefulness of an abnormal white blood cell count for predicting a concurrent serious bacterial infection in infants and young children hospitalized with respiratory syncytial virus lower respiratory tract infection.
Purcell K; Fergie J
Pediatr Infect Dis J; 2007 Apr; 26(4):311-5. PubMed ID: 17414393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
